Literature DB >> 29746142

Pulmonary Vascular Involvement in Chronic Obstructive Pulmonary Disease. Is There a Pulmonary Vascular Phenotype?

Gabor Kovacs1,2, Alvar Agusti3,4, Joan Albert Barberà3,4, Bartolome Celli5, Gerard Criner6, Marc Humbert7, Don D Sin8,9, Norbert Voelkel10, Horst Olschewski1,2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29746142     DOI： 10.1164/rccm.201801-0095PP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  31 in total

1.  How to Detect Tobacco-related Vasculopathy: Are We There Yet?

Authors:  Jarrod Barnes; Stefanie Krick
Journal:  Ann Am Thorac Soc       Date:  2019-06

2.  Cigarette Smoke Exposure and Radiographic Pulmonary Vascular Morphology in the Framingham Heart Study.

Authors:  Andrew J Synn; Chunyi Zhang; George R Washko; Raúl San José Estépar; George T O'Connor; Wenyuan Li; Murray A Mittleman; Mary B Rice
Journal:  Ann Am Thorac Soc       Date:  2019-06

3.  Arterial Vascular Pruning, Right Ventricular Size, and Clinical Outcomes in Chronic Obstructive Pulmonary Disease. A Longitudinal Observational Study.

Authors:  George R Washko; Pietro Nardelli; Samuel Y Ash; Gonzalo Vegas Sanchez-Ferrero; Farbod N Rahaghi; Carolyn E Come; Mark T Dransfield; Ravi Kalhan; MeiLan K Han; Surya P Bhatt; J Michael Wells; Carrie Pistenmaa Aaron; Alejandro A Diaz; James C Ross; Michael J Cuttica; Wassim W Labaki; Gabriela Querejeta Roca; Amil M Shah; Kendra Young; Gregory L Kinney; John E Hokanson; Alvar Agustí; Raúl San José Estépar
Journal:  Am J Respir Crit Care Med       Date:  2019-08-15       Impact factor: 21.405

Review 4.  Potential role of exercise echocardiography and right heart catheterization in the detection of early pulmonary vascular disease in patients with systemic sclerosis.

Authors:  Gabor Kovacs; Horst Olschewski
Journal:  J Scleroderma Relat Disord       Date:  2019-05-24

5.  Journal Club: Impaired Ventilatory Efficiency and Exercise Intolerance in Former/Current Smokers With Dyspnea Disproportionate to Their Lung Function: Pathophysiological Insights Gained Through Cardiopulmonary Exercise Testing.

Authors:  Ron Balkissoon; Takudzwa Mkorombindo
Journal:  Chronic Obstr Pulm Dis       Date:  2022-07-29

6.  Clinical insights into pulmonary hypertension in chronic obstructive pulmonary disease.

Authors:  Daniel P Cook; Meng Xu; Victoria L Martucci; Jeffrey S Annis; Melinda C Aldrich; Anna R Hemnes; Evan L Brittain
Journal:  Pulm Circ       Date:  2022-01-03       Impact factor: 2.886

7.  Diffusing Capacity Is an Independent Predictor of Outcomes in Pulmonary Hypertension Associated With COPD.

Authors:  Aparna Balasubramanian; Todd M Kolb; Rachel L Damico; Paul M Hassoun; Meredith C McCormack; Stephen C Mathai
Journal:  Chest       Date:  2020-03-14       Impact factor: 9.410

8.  Pulmonary vasodilator treatment in pulmonary hypertension due to left heart or lung disease: time for a high-definition picture?

Authors:  Lucilla Piccari; Roberto J Bernardo; Diego Rodríguez-Chiaradía; Patrizio Vitulo; S John Wort; Sandeep Sahay
Journal:  Pulm Circ       Date:  2021-05-29       Impact factor: 3.017

Review 9.  Updated Perspectives on Pulmonary Hypertension in COPD.

Authors:  Isabel Blanco; Olga Tura-Ceide; Victor Ivo Peinado; Joan Albert Barberà
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-06-09

10.  Management of Pulmonary Hypertension Due to Chronic Lung Disease.

Authors:  Jordan Sugarman; Jason Weatherald
Journal:  Methodist Debakey Cardiovasc J       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.